Intralipid Emulsion
NDC Package 0338-0519-58
Package Information
Intralipid (i.v. fat emulsion) emulsions is a medication used to provide calories to patients who are getting their nutrition through an injection into the vein. This formulation utilizes a emulsion delivery system. Marketed by Baxter Healthcare Corporation, this product is identified by NDC 0338-0519 and is authorized under FDA application NDA020248.
Identification & Billing
- RxCUI: 1799694 - soybean oil 20 % in 100 ML Injection
- RxCUI: 1799694 - 100 ML soybean oil 200 MG/ML Injection
- RxCUI: 1799694 - soybean oil 20 % per 100 ML Injection
- RxCUI: 1799696 - Intralipid 20 % in 100 ML Injection
- RxCUI: 1799696 - 100 ML soybean oil 200 MG/ML Injection [Intralipid]
Clinical Specifications
- Intravenous - Administration within or into a vein or veins.
- Intravenous - Administration within or into a vein or veins.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 0338 - Baxter Healthcare Corporation
- 0338-0519 - Intralipid
- 0338-0519-58 - 100 mL in 1 BAG
- 0338-0519 - Intralipid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0338-0519). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0338-0519-58 identifies a specific commercial package of 100 ml in 1 bag of Intralipid, a human prescription drug labeled by Baxter Healthcare Corporation. This product is billed per "ML" milliliter and contains an estimated amount of 100 billable units per package. This emulsion is formulated for intravenous use and contains soybean oil as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Baxter Healthcare Corporation on April 01, 2004. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This product is used to provide calories to patients who are getting their nutrition through an injection into the vein. Calories are needed to provide the body with energy so that the body can work properly. This product is also used to provide a certain nutrient (essential fatty acids) to people who do not have enough of it. This product helps to prevent or reverse the signs of this deficiency (e.g., scaly skin, poor growth, poor wound healing).
How is this Baxter Healthcare Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00338051958. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
